Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06642831
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-09
Brief Title:
Polycystic Ovarian Syndrome PCOS Biomarker Evaluation Study
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Polycystic Ovarian Syndrome PCOS in Human Adolescent and Young Adult Females - Biomarker Evaluation Study PHOEBE
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PHOEBE
Brief Summary:
The purpose of the study is to validate recently identified biomarkers for the identification of PCOS in adolecent and young adult women
Detailed Description:
The purpose of the study is to validate potential biomarkers for the aid in the diagnosis of PCOS in adolescent and young adult women in the age range of 15-25 years Female subjects included in this study will have one visit where clinical data for assessing PCOS will be collected and a blood draw will be performed to collect serum for measurement of parameters relevant to PCOS will be performed Study subjects that receive a PCOS diagnosis will have two follow up visits for follow up on treatment where additional serum and clinical data will be collected The first visit will be 3 months after receiving the diagnosis and the second visit 6-12 months after the initial visit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None